Is D-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6
Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of D-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: D-R (THB3.26) is trading below our estimate of fair value (THB7.34)
Significantly Below Fair Value: D-R is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for D-R?
Key metric: As D-R is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for D-R. This is calculated by dividing D-R's market cap by their current
earnings.
What is D-R's PE Ratio?
PE Ratio
18.5x
Earnings
฿60.44m
Market Cap
฿1.12b
D-R key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: D-R is good value based on its Price-To-Earnings Ratio (18.5x) compared to the TH Healthcare industry average (22x).
Price to Earnings Ratio vs Fair Ratio
What is D-R's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
D-R PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
18.5x
Fair PE Ratio
n/a
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate D-R's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.